Navigation Links
CRO Solutions, Inc. Announces Opening of New Division - VxP Pharma Services, Inc.
Date:7/22/2013

INDIANAPOLIS, July 22, 2013 /PRNewswire/ -- CRO Solutions, Inc. announced the launch of VxP Pharma, Inc.- a wholly owned subsidiary of CRO Solutions, Inc. VxP Pharma is comprised of the combined services of the independently owned and operated "niche" CROs of parent company - CRO Solutions, Inc. VxP Pharma will offer pharmaceutical development services, as well as technical support, for the development and production of pharmaceuticals, diagnostics, and drug/device combination products from Discovery through Phase IIb.

The majority of VxP Pharma's Labs are located in the United States, although VxP also has facilities in Europe and Asia. All VxP sites have been fully audited by CRO Solutions/VxP Pharma, as well as by global pharmaceutical and biotechnology clients. Most sites have also been audited by the US FDA as well as other international regulatory agencies.

VxP Pharma CEO - Raymond E Peck says "Pharmaceutical and biotech research scientists throughout the industry tell us that they prefer to work with smaller, focused, Contract Research Organizations (CROs), rather than with the huge multinational 'one-size-fits-all' CROs. For these people, VxP Pharma is a perfect fit because we offer a single point of contact, as well as the confidence that, if you work with VxP, you are working with a state-of-the-art lab that has been subject to a complete audit, including, in most cases, an audit by the US FDA. Because VxP consists of smaller, independently owned and operated facilities who focus on only one area of drug development, our drug development clients get all the advantages of working directly with a specialist "niche" CRO, including being able to work with some of the best subject matter experts in the industry."

VxP Pharma will operate as a full service CRO offering drug development services from Discovery through Phase llb. VxP is headquartered in Indianapolis, Indiana. To find out more, please visit: www.vxppharma.com or call at 317-759-2299.

Press Release Contact Information:
Lisa Fay
Director of Client Development
VxP Pharma Services, Inc.
317-759-2299
Lisa.Fay@VxPPharma.com

This release was issued through WebWire(R). For more information visit http://www.webwire.com.


'/>"/>
SOURCE VxP Pharma Services, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. MEDIFIRST SOLUTIONS, INC. To Exhibit At The Orlando International Beauty Show
2. Medifirst Solutions, Inc. Announces Update To Shareholders
3. Medifirst Solutions, Inc. Announces New Healthcare And Wellness Division
4. Comprehensive Care Corporation Names Colonel Ramon Martinez President of CompCare Pharmacy Solutions, Inc.
5. Care Corporation Names Colonel Ramon Martinez President of CompCare Pharmacy Solutions, Inc.
6. inVentiv Health Forms Strategic Alliance With Bell Medical Solutions, One Of Japans Top Clinical Research Organizations
7. Managed Health Care Associates, Inc. (MHA) Announced Erik Halstrom, Vice President of MHA Specialty Pharmacy Solutions, Will Serve on the National Association of Specialty Pharmacy (NASP) Board of Directors
8. Qualyst Transporter Solutions, LLC Announces New Alliance with GenoMembrane
9. Cardinal Health Specialty Solutions, Health Alliance Plan Work With Michigan Oncologists to Improve Quality, Curb Costs of Cancer Care
10. Catalent Pharma Solutions, Inc. Announces Increase In Tender Cap For Its Cash Tender Offer For Its 9-1/2%/10-1/4% Senior PIK-Election Notes Due 2015
11. Catalent Pharma Solutions, Inc. Announces Cash Tender Offer for up to $250 Million of Its 9-1/2%/10-1/4% Senior PIK-Election Notes due 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... The primary goal of this research is to analyze ... of liquid biopsy. Key information the survey seeks to ... liquid biopsy adoption amidst future users - Predominantly used ... Sample inflow to conduct liquid biopsy tests - Preference ... on. - Correlation analysis of sample type and biomarker ...
(Date:2/11/2016)... PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial results for its ... also filed its Quarterly Report on Form 10-Q for the ... Exchange Commission today. --> --> ... --> Net sales for the three months ... $5.4 million from $2.8 million for the three months ended ...
(Date:2/11/2016)... 2016  Kindred Biosciences, Inc. (NASDAQ: KIN ), ... lives of pets, today announced the submission to FDA ... Drug Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive ... Zimeta for the control of pyrexia (fever) in horses ... --> --> The Chemistry, Manufacturing, and ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... ... initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced skills needed to introduce ... from U.S. universities who will draw from Siemens’ deep knowledge of product ...
(Date:2/12/2016)... ... ... Each year, the American Physical Therapy Association (APTA) offers a Combined Sections Meeting. ... Almost 10,000 physical therapists across the country are expected to attend this annual convention ... field and network with their colleagues. As in years past, HydroWorx is proud ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ... Zuckerberg San Francisco General Hospital on April 5-7. The series is a multi-day, ... new habits. The workshops cover a broad range of topics, including coaching skills, ...
(Date:2/12/2016)... ... , ... AssureVest Insurance Group, a locally owned insurance firm with offices serving ... funds earmarked to purchase computers and software for Mrs. Harrison’s 2nd and 3rd grade ... a low-income area and has more than 60 2nd and 3rd graders with learning ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... the Pittsburgh metro area, celebrates the beginning of the latest charity campaign in ... social skills through art. Donations to this worthy cause are currently being accepted ...
Breaking Medicine News(10 mins):